Werewolf Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	122.83	134.34	129.32	157.53	92.57	17.9
Cash & Short-Term Investments	122.83	134.34	129.32	157.53	92.57	17.9
Cash Growth	-5.56%	3.89%	-17.91%	70.18%	417.27%	-
Accounts Receivable	-	0.4	4.1	-	-	-
Other Receivables	0.46	0.95	2.83	-	-	-
Receivables	0.46	1.35	6.93	-	-	-
Prepaid Expenses	2.54	2.47	3.96	3.44	0.34	0.09
Restricted Cash	-	0.21	-	0.1	-	-
Other Current Assets	-	-	-	-	-	0.08
Total Current Assets	125.84	138.37	140.2	161.07	92.91	18.06
Property, Plant & Equipment	12.94	14.85	17.45	16.33	3.12	3.41
Long-Term Deferred Charges	-	-	-	-	0.16	-
Other Long-Term Assets	1.26	21.62	2.59	1.86	0.21	0.21
Total Assets	140.04	174.83	160.25	179.25	96.4	21.68
Accounts Payable	1.24	1.34	1.22	2.04	1.02	0.63
Accrued Expenses	9.45	8.41	13.41	8.6	3.49	0.82
Current Portion of Long-Term Debt	-	6.67	-	-	-	-
Current Portion of Leases	1.32	1.61	2.08	1.07	0.68	0.6
Current Unearned Revenue	-	0.91	6.53	-	-	-
Other Current Liabilities	0.45	0.45	0.74	0.16	0.09	-
Total Current Liabilities	12.46	19.38	23.99	11.87	5.28	2.04
Long-Term Debt	25.62	32.66	-	-	-	-
Long-Term Leases	9.84	10.99	12.6	14.59	1.86	2.54
Long-Term Unearned Revenue	-	0.43	1.13	-	-	-
Other Long-Term Liabilities	2.74	-	0.19	-	0.03	7.32
Total Liabilities	50.66	63.46	37.91	26.46	7.18	11.91
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	483.56	455.44	429.04	405.68	-	0.1
Retained Earnings	-394.19	-344.07	-306.71	-252.9	-51.87	-24.41
Total Common Equity	89.38	111.37	122.34	152.79	-51.86	-24.3
Shareholders' Equity	89.38	111.37	122.34	152.79	89.22	9.77
Total Liabilities & Equity	140.04	174.83	160.25	179.25	96.4	21.68
Total Debt	36.78	51.92	14.68	15.66	2.54	3.14
Net Cash (Debt)	86.05	82.42	114.63	141.87	90.03	14.76
Net Cash Growth	10.50%	-28.10%	-19.20%	57.58%	509.99%	-
Net Cash Per Share	2.08	2.31	3.97	7.69	89.58	23.10
Filing Date Shares Outstanding	44.56	42.74	35.28	27.65	1.75	0.64
Total Common Shares Outstanding	43.72	39.11	31.52	27.61	1.75	0.64
Working Capital	113.37	118.99	116.21	149.19	87.63	16.02
Book Value Per Share	2.04	2.85	3.88	5.53	-29.70	-38.03
Tangible Book Value	89.38	111.37	122.34	152.79	-51.86	-24.3
Tangible Book Value Per Share	2.04	2.85	3.88	5.53	-29.70	-38.03
Machinery	-	3.16	2.32	1.07	0.64	0.26
Construction In Progress	-	-	0.11	1.96	-	-
Leasehold Improvements	-	7.97	7.97	0.27	0.19	0.01

Source: S&P Capital IQ. Standard template. Financial Sources.